Venous thrombosis in familial thrombophilia 1531
/C2112004 International Society on Thrombosis and Haemostasis
 15387836, 2004, 9, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2004.00852.x by Readcube (Labtiva Inc.), Wiley Online Library on [25/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
6 Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M,
Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-termclinical course of acute deep venous thrombosis. A n nI n t e r nM e d 1996;
125: 1–7.
7 Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk
and interaction. Semin Hematol 1997; 34: 171–87.
8 Bovill EG, Bauer KA, Dickerman J D, Callas P, West B. The clinical
spectrum of heterozygous protein C deﬁciency in a large New England
kindred. Blood 1989; 73: 712–7.
9 Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder.
Thromb Haemost 1997; 78: 297–301.
10 Rosendaal FR. Venous thromb osis: a multicausal disease. Lancet
1999; 353: 1167–73.
11 Lensen RP, Rosendaal FR, Koster T, Allaart CF, de Ronde H,
Vandenbroucke JP, Reitsma PH, Bertina RM. Apparent diﬀerent
thrombotic tendency in patients with factor V Leiden and protein C
deﬁciency due to selection of patients. Blood 1996; 88: 4205–8.
12 Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal
FR. Venous thrombotic risk in family members of unselected indi-
viduals with factor V Leiden. Thromb Haemost 2000; 83: 817–21.
13 Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP,
Boulyjenkov V, Chandy M, Dahlba ¨ck B, Ginter EK, Miletich JP,
Rosendaal FR, Seligsohn U. Inh erited thrombophilia: Part 1. Thromb
Haemost 1996; 76: 651–62.
14 Egeberg O. Inherited antithrombin deﬁciency causing thrombophilia.
Thromb Diath Haemorrh 1965; 13: 516–30.
15 Griﬃn JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deﬁci-
ency of protein C in congenital thrombotic disease. JC l i nI n v e s t 1981;
68: 1370–3.
16 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S
deﬁciency is associated with recurrent thrombosis. J Clin Invest 1984;
74: 2082–8.
17 Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de
Ronde H, van der Velden PA, Reitsma PH. Mutation in blood
coagulation factor V associated with resistance to activated protein C.Nature 1994; 369: 64–7.
18 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common
genetic variation in the 3 ¢-untranslated region of the prothrombin gene
is associated with elevated plasma prothrombin levels and an increase
in venous thrombosis. Blood 1996; 88: 3698–703.
19 Wissenschaftliche Tabellen Geigy, Teilband Statistik Vol. 8. Basel.
1980; 152.
20 Koeleman BP, Reitsma PH, Allaart CF, Bertina RM. Activated pro-
tein C resistance as an additional risk factor for thrombosis in proteinC-deﬁcient families. Blood 1994; 84: 1031–5.
21 Boven HH, Reitsma PH, Rosendaa l FR, Bayston TA, Chowdhury V,
Bauer KA, Scharrer I, Conard J, Lane DA. Factor V Leiden (FVR506Q) in families with inheri ted antithrombin deﬁciency. Thromb
Haemost 1996; 75: 417–21.
22 Zo ¨l l e rB ,B e r n t s d o t t e rA ,G a r c ı ´ad eF r u t o sP ,D a h l b a ¨ck B. Resistance
to activated protein C as an additional genetic risk factor in hereditary
deﬁciency of protein S. Blood 1995; 85: 3518–23.
23 Bucciarelli P, Rosend aal FR, Tripodi A, Mannucci PM, De Stefano V,
Palareti G, Finazzi G, Baudo F, Quintavalla R. Risk of venous
thromboembolism and clinical ma nifestations in carriers of anti-
thrombin, protein C, protein S deﬁciency, or activated protein Cresistance: a multicenter c ollaborative family study. Arterioscler
Thromb Vasc Biol 1999; 19: 1026–33.
24 Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F,
Paciaroni K, Leone G, Faioni EM. Diﬀerent risks of thrombosis infour coagulation defects associated with inherited thrombophilia: astudy of 150 families. Blood 1998; 92: 2353–8.
25 Boven HH, Vandenbroucke JP, Brie ¨t E, Rosendaal FR. Gene-gene
and gene–environment interactions determine risk of thrombosis infamilies with inherited antithrombin deﬁciency. Blood 1999; 94: 2590–
4.
26 Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Gi-
rolami B, Gavasso S, Huisman M, Bu ¨ller HR, ten Cate JW, Girolami
A, Prins MH. Incidence of venous t hromboembolism in families with
inherited thrombophilia. Thromb Haemost 1999; 81: 198–202.
27 De Stefano V, Leone G, Mastrangelo S, Tripodi A, Rodeghiero F,
Castaman G, Barbui T, Finazzi G, Bizzi B, Mannucci PM. Clinicalmanifestations and management of inherited thrombophilia: retro-
spective analysis and follow-up after diagnosis of 238 patients with
congenital deﬁcienc y of antithrombin III, protein C, protein S. Thromb
Haemost 1994; 72: 352–8.
28 Finazzi G, Barbui T.